Calidi Biotherapeutics Inc (CLDI) Stock Price, Quote & News

Company Profile

Calidi Biotherapeutics, Inc., a biotechnology company, develops targeted therapies to deliver genetic medicines to distal sites of disease. The company offers CLD-101, which is in Phase 1b/2 clinical trial for the treatment of newly diagnosed high grade glioma, as well as in Phase 1 dose-escalation clinical trial for recurrent high-grade glioma; CLD-201 product for solid tumors, such as breast cancer, head and neck cancer, and sarcoma; and CLD-401 for the treatment of metastatic solid tumors. It...

Industry: Biotechnology

Sector: Healthcare

Phone: 858 794 9600

Fax: 858 794 9605

Website: www.calidibio.com

Address:

4475 Executive Drive, Suite 200, San Diego, United States

Sabby_Management Jul. 3 at 8:14 PM

$CLDI @Spy_Guy you have been quiet.

1 · Reply

race2zero Jul. 3 at 1:40 PM

$CLDI @QQQ_Guy @Sabby_Management @Spy_Guy

0 · Reply

Sabby_Management Jul. 3 at 1:09 AM

$CLDI @Spy_Guy where are you?

0 · Reply

race2zero Jul. 3 at 1:08 AM

$CLDI @Spy_Guy it isn’t too late to join the short crew and destroy this POS on the reverse split

1 · Reply

race2zero Jul. 3 at 12:54 AM

$CLDI it’s so easy! Eric Poma just keeps embarrassing himself doing these stupid interview/podcasts or whatever you want to call them! He remained completely silent for almost a year and now that he needs money he is trying to promote his garbage company desperately. It really is fun to watch! What color lambo you getting? I’m thinking matte black. I’ll even give @QQQ_Guy a ride for finally becoming a bear

1 · Reply

Sabby_Management Jul. 3 at 12:11 AM

$CLDI I just wanted to Thank Eric and Calidi for this opportunity to get a free house and lambo from shorting this scam. Easiest money ever. Better sell now @Spy_Guy

0 · Reply

race2zero Jul. 2 at 11:42 PM

$CLDI first person in history to make money as a bull with a quick flip for .50

0 · Reply

Sabby_Management Jul. 2 at 11:21 PM

$CLDI there is only 1 bull left where you at @Spy_Guy

0 · Reply

race2zero Jul. 2 at 9:37 PM

$CLDI someone is trying to unload 15k shares at .152🤣🤣I wonder why🤣🤣

0 · Reply

race2zero Jul. 2 at 8:05 PM

$CLDI solid days work…one day close to the reverse split and dilution for retirement. Also, eliminated one bull today when @QQQ_Guy finally admitted the company sucks. There are now zero bulls left

1 · Reply

Calidi Biotherapeutics Presents New Data on CLD-501, Its In Situ T-Cell Engager Candidate Targeting TROP-2 at the T-Cell Engager Therapeutic Summit

Jun 23, 2026, 8:00 AM EDT - 11 days ago

Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.D., to Board of Directors

2026-06-16T12:39:20.000Z - 18 days ago

Calidi receives pre-IND regulatory feedback from FDA for CLD-401

Jun 16, 2026, 8:00 AM EDT - 18 days ago

Calidi Biotherapeutics Receives Positive Pre-IND Feedback from US FDA for CLD-401 Indicating Agreement on its Current Development Strategy as it Advances Towards a First-in-Human Study

Jun 8, 2026, 8:00 AM EDT - 26 days ago

Calidi Biotherapeutics Announces Investor Webinar on June 9, 2026

2026-05-26T15:37:20.000Z - 5 weeks ago

Calidi announces online abstract acceptances at 2026 ASCO Meeting

May 26, 2026, 8:00 AM EDT - 5 weeks ago

Calidi Biotherapeutics Announces Online Abstract Acceptances at the 2026 ASCO Annual Meeting

2026-05-22T22:05:57.000Z - 6 weeks ago

Calidi provides required NYSE American disclosure

May 22, 2026, 6:00 PM EDT - 6 weeks ago

Calidi Biotherapeutics Provides Required NYSE American Disclosure

May 14, 2026, 4:10 PM EDT - 7 weeks ago

Calidi Biotherapeutics Reports First Quarter 2026 Financial Results and Recent Operational Highlights

May 13, 2026, 8:00 AM EDT - 7 weeks ago

Calidi Biotherapeutics Confirms Featured Speaker Presentation Tomorrow at the ASGCT Conference in Boston

Apr 29, 2026, 8:00 AM EDT - 2 months ago

Calidi Biotherapeutics Announces Strategic Partnership with TransferAI to Drive Efficiencies in the IND Submission Process for CLD-401 Using Agentic AI

2026-04-21T13:29:48.000Z - 2 months ago

Calidi presents new data on CLD-401 at AACR

2026-04-20T12:54:38.000Z - 2 months ago

Calidi presents new data on in situ t-cell engagers at AACR

Apr 20, 2026, 8:00 AM EDT - 2 months ago

Calidi Biotherapeutics Presents New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026

Mar 27, 2026, 4:25 PM EDT - 3 months ago

Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Operational Highlights

2026-03-12T12:17:48.000Z - 4 months ago

Calidi presents manufacturing process for CDI-401 at BioProcessing Summit

Mar 12, 2026, 8:00 AM EDT - 4 months ago

Calidi Biotherapeutics Presents its Innovative and Scalable Manufacturing Process for CLD-401 at the 9th Annual Bioprocessing Summit; FDA Feedback Support Company's Approach to Manufacturing

Mar 9, 2026, 8:50 PM EDT - 4 months ago

Calidi Biotherapeutics Announces Closing of $6.0 Million Underwritten Public Offering and Full Exercise of Underwriters' Over-Allotment Option

2026-03-06T13:35:48.000Z - 4 months ago

Calidi prices 10.5M units at 50c in underwritten public offering

Mar 6, 2026, 8:30 AM EST - 4 months ago

Calidi Biotherapeutics Announces Pricing of $5.2 Million Underwritten Public Offering

2026-03-05T23:00:46.000Z - 4 months ago

Calidi announces offering of units, no amount given

Mar 5, 2026, 5:57 PM EST - 4 months ago

Calidi Biotherapeutics Announces Proposed Public Offering

2026-02-20T13:11:19.000Z - 4 months ago

Calidi presents data on novel approach to use of BiTEs

Feb 20, 2026, 8:00 AM EST - 4 months ago

Calidi Biotherapeutics Presents Data on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform at the 2026 AACR-IO Conference

2026-02-12T13:10:13.000Z - 5 months ago

Calidi to present on approach to bispecific T-cell engagers using RedTail

Feb 12, 2026, 8:00 AM EST - 5 months ago

Calidi Biotherapeutics To Present on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform in a Late-Breaking Abstract at the 2026 AACR-IO Conference

2026-01-28T13:13:01.000Z - 5 months ago

Calidi announces 2026 milestones

Nov 17, 2025, 8:00 AM EST - 8 months ago

Calidi Biotherapeutics Announces Exclusive Live Investor Webinar and Q&A Session on November 19, 2025

Nov 13, 2025, 4:15 PM EST - 8 months ago

Calidi Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Operational Highlights

2025-11-10T13:20:35.000Z - 8 months ago

Calidi presents new data on CLD-401 at 2025 SITC annual meeting

2025-10-30T12:15:32.000Z - 8 months ago

Calidi announces new data to be presented on CLD-401 at 2025 SITC meeting

2025-10-22T12:11:42.000Z - 9 months ago

Calidi announces formation of its Scientific Advisory Board

Aug 21, 2025, 6:33 PM EDT - 11 months ago

Calidi Biotherapeutics Announces Closing of $6.9 Million Underwritten Public Offering and Full Exercise of Underwriters' Over-Allotment Option

2025-08-20T13:20:27.000Z - 11 months ago

Calidi prices 1.47M units at $2.00 in underwritten public offering

Aug 20, 2025, 9:15 AM EDT - 11 months ago

Calidi Biotherapeutics Announces Pricing of $6 Million Underwritten Public Offering

Aug 8, 2025, 4:15 PM EDT - 11 months ago

Calidi Biotherapeutics Reports Second Quarter 2025 Financial Results and Recent Operational Highlights

2025-08-05T13:46:30.000Z - 11 months ago

Calidi Biotherapeutics Inc trading resumes

2025-08-05T13:43:07.000Z - 11 months ago

Calidi Biotherapeutics Inc trading halted, volatility trading pause

2025-07-29T12:22:15.000Z - 1 year ago

Calidi receives FDA Fast Track designation for CLD-201

Jul 25, 2025, 4:45 PM EDT - 1 year ago

Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on August 5, 2025

Jul 22, 2025, 8:00 AM EDT - 1 year ago

Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on July 24

Jul 10, 2025, 8:30 AM EDT - 1 year ago

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Platform Designed to Transform Landscape of Cancer Treatment

Jul 9, 2025, 2:01 PM EDT - 1 year ago

Calidi Biotherapeutics Announces Exercise of Warrants for $4.6 Million of Gross Proceeds

Jul 8, 2025, 8:30 AM EDT - 1 year ago

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Developing Precision Genetic Medicine Platform for Cancer Treatment

Jun 27, 2025, 8:00 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Shareholder Letter from CEO

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711

Apr 16, 2025, 9:30 AM EDT - 1 year ago

Global X Offers Precise U.S. Equity Exposure with Launch of Domestic Focused Funds

EGLE

Mar 31, 2025, 4:30 PM EDT - 1 year ago

Calidi Biotherapeutics Announces Closing of $3.9 Million Registered Direct Offering and Concurrent Private Placement

Mar 28, 2025, 9:00 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Pricing of $3.9 Million Registered Direct Offering and Concurrent Private Placement

Mar 10, 2025, 8:00 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Demonstrated Ability To Deliver Transient Gene Therapy (Payload) To Tumors Using Systemic Platform

Feb 28, 2025, 9:00 AM EST - 1 year ago

Calidi Biotherapeutics and OS Therapies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

OSTX

Feb 24, 2025, 8:00 AM EST - 1 year ago

Calidi Biotherapeutics Announces Commencement of Recruitment for Multiple Dose CLD-101 Trial in Patients with Newly Diagnosed High Grade Glioma at Northwestern University Hospital

Jan 29, 2025, 8:00 AM EST - 1 year ago

Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on February 5

Jan 28, 2025, 8:00 AM EST - 1 year ago

Calidi Biotherapeutics Announces Bolstered Cash Balance and Termination of its Standby Equity Purchase Agreement

Jan 10, 2025, 4:30 PM EST - 1 year ago

Calidi Biotherapeutics Announces Closing of $4.25 Million Public Offering of Common Stock

Jan 10, 2025, 8:30 AM EST - 1 year ago

Calidi Biotherapeutics Announces Pricing of $4.25 Million Public Offering of Common Stock

Nov 15, 2024, 4:05 PM EST - 1 year ago

Calidi Biotherapeutics Announces Closing of $7.5 Million Public Offering of Common Stock

Nov 14, 2024, 8:30 AM EST - 1 year ago

Calidi Biotherapeutics Announces Pricing of $7.5 Million Public Offering of Common Stock

Nov 12, 2024, 5:29 PM EST - 1 year ago

Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results

Oct 25, 2024, 9:00 AM EDT - 1 year ago

Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

NXL

Oct 24, 2024, 8:30 AM EDT - 1 year ago

Calidi Biotherapeutics to Present Data Supporting RTNova at Upcoming Scientific Conferences

Oct 23, 2024, 8:31 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement

Oct 18, 2024, 11:00 PM EDT - 1 year ago

NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS)

Oct 18, 2024, 8:45 AM EDT - 1 year ago

Calidi Biotherapeutics and Gorilla Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

GRRR

Sabby_Management Jul. 3 at 8:14 PM

$CLDI @Spy_Guy you have been quiet.

1 · Reply

race2zero Jul. 3 at 1:40 PM

$CLDI @QQQ_Guy @Sabby_Management @Spy_Guy

0 · Reply

Sabby_Management Jul. 3 at 1:09 AM

$CLDI @Spy_Guy where are you?

0 · Reply

race2zero Jul. 3 at 1:08 AM

$CLDI @Spy_Guy it isn’t too late to join the short crew and destroy this POS on the reverse split

1 · Reply

race2zero Jul. 3 at 12:54 AM

1 · Reply

Sabby_Management Jul. 3 at 12:11 AM

$CLDI I just wanted to Thank Eric and Calidi for this opportunity to get a free house and lambo from shorting this scam. Easiest money ever. Better sell now @Spy_Guy

0 · Reply

race2zero Jul. 2 at 11:42 PM

$CLDI first person in history to make money as a bull with a quick flip for .50

0 · Reply

Sabby_Management Jul. 2 at 11:21 PM

$CLDI there is only 1 bull left where you at @Spy_Guy

0 · Reply

race2zero Jul. 2 at 9:37 PM

$CLDI someone is trying to unload 15k shares at .152🤣🤣I wonder why🤣🤣

0 · Reply

race2zero Jul. 2 at 8:05 PM

$CLDI solid days work…one day close to the reverse split and dilution for retirement. Also, eliminated one bull today when @QQQ_Guy finally admitted the company sucks. There are now zero bulls left

1 · Reply

race2zero Jul. 2 at 8:02 PM

$CLDI 🤣🤣🤣🤣🤣@CalidiOfficial

0 · Reply

NetworkNewsWire Jul. 2 at 7:42 PM

Comprehensive Review Shows Gut Microbiome Influences Immunotherapy Efficacy $CLDI https://ibn.fm/ZTKSL #biomed #stocks

0 · Reply

race2zero Jul. 2 at 5:19 PM

$CLDI @Banana3 where did you go tough guy? Talking all tough and then disappeared like a little B. I told you that you couldn’t and wouldn’t win against me….I own you

0 · Reply

race2zero Jul. 2 at 5:17 PM

$CLDI price target once reverse split date is announced $0.08. They needed to raise to .40 for the split to provide enough $$ on dilution according to my source, but they can’t do it. They are giving up and will go ahead and go through with the split and get what they can from dilution before shutting down. Reverse split could be announced today AH with market closed tomorrow to take effect on Monday. If you have any shares, I’d get out as fast as possible before you lose about 40-50% on the date announcement

0 · Reply

race2zero Jul. 2 at 4:42 PM

$CLDI bruh, it’s complete garbage run my idiots that only want your money through dilution

0 · Reply

ka1954 Jul. 2 at 4:29 PM

$CLDI why this fucking piece of trash can't be green for more than 1 day ?

0 · Reply

race2zero Jul. 2 at 4:17 PM

$CLDI soon they will give up on trying to raise the price before the reverse split, they will accept the fact that the company is dead and they will RS and dilute and only use the money to pay themselves and not waste it on research or development. It won’t be enough money for them to survive…

0 · Reply

race2zero Jul. 2 at 12:24 PM

$CLDI I’ll make you a deal, I won’t turn this into the authorities if you finally answer as to why you are bullish. Actual answers not gibberish…:

1 · Reply

race2zero Jul. 2 at 12:01 PM

$CLDI if we find out he works for or has any connection to Poma with his buyout post below it will be amazing to watch the company go down in flames for his fraudulent AI post below…might just have to turn it into the SEC for fun

1 · Reply

Donald_J_Dumps Jul. 2 at 5:42 AM

$CLDI lol quit trying to pump, i bet you work for Mr. Poma. No one wants to buy this garbage a buyout will never happen.

0 · Reply

QQQ_Guy Jul. 2 at 4:45 AM

$CLDI there will probably be a buyout this week guys.

0 · Reply

race2zero Jul. 2 at 2:26 AM

$CLDI just saying..:

1 · Reply

Market Cap	2.88M
Revenue (ttm)	0.00
Net Income (ttm)	-19.91M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.12

Volume	3,064,200
Avg Vol	6,821,788
Day's Range	N/A - N/A
Shares Out	19.31M
Stochastic %K	11%
Beta	1.30
Analysts	Strong Buy
Price Target	$10.00